- Asthma Center
- Allergy & Immunology
- Childhood Cancer
- Childrens Express Care
- Ear, Nose & Throat (ENT)
- Emergency Medicine
- Infectious Diseases
- Medical Genetics
- Newborn Medicine
- Primary Care
- Transplant Programs
- International Services
- Health Info Management
- Poison Control Center
- Ronald McDonald House
- Social Work
- Telemedicine Program
- Volunteer Services
- Welcome/Info Center
Patients and Families
Planning a Visit
- Get Directions
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
- Safety Center
- Adolescent Medicine
- Babysitting Class
- Diseases & Conditions
- Drugs and Alcohol
- Injury Prevention
- Schools & Jobs
- Sexual Health
- Teen Health
- For Health Professionals
- Ways to Give
- Childhood Disability Rates Highest Recorded
- Express Care Opens New Location
- Board of Trustees Leadership Changes
Transplant Survival Rates
The Hillman Center for Pediatric Transplantation at Children’s Hospital of Pittsburgh of UPMC has performed more pediatric transplants than any other pediatric transplant center. Our transplant survival rates consistently beat the national average and are among the world’s best.
Transplant Survival Rates*
Liver Transplant Survival
|1 Year||100%||national average||95%|
|3 Years||95%||national average||91%|
Children’s Hospital of Pittsburgh has performed more than 1,600 pediatric liver transplants in children to date, making it the most active pediatric liver transplant center in the country.
Learn more about Children’s Hospital’s liver transplant program outcomes.
Intestine Transplant Survival
|1 Year||73%||national average||87%|
|3 Years||87%||national average||68%|
Children's Hospital has performed more pediatric intestinal transplants than any other center in the country. Patients of Children’s pediatric intestinal transplant program represent the world’s first and most successful series of small intestine transplants.
Learn more about Children’s Hospital’s intestine transplant program outcomes.
Heart Transplant Survival
|1 Year||100%||national average||93%|
|3 Years||90%||national average||84%|
Children's Hospital has performed more than 400 heart/lung transplants in children to date, including more than 280 pediatric heart transplants, making it one of the most active pediatric transplant centers in the world.
Learn more about Children’s Hospital’s heart transplant program outcomes.
Lung Transplant Survival
|1 year||100%||national average||87%|
|3 Years||100%||national average||62%|
Our transplant team performs double- and single-lung transplants for children suffering from lung disease including cystic fibrosis and pulmonary hypertension.
Learn more about Children’s Hospital’s lung transplant program outcomes.
Heart-Lung Transplant Survival
|Patients transplanted 2006-2010||76%|
Children's Hospital performed the first successful pediatric heart-lung transplant in 1985. Since then our team has performed more pediatric heart-lung transplants than any other center in the country.
Learn more about Children’s Hospital’s cardiopulmonary transplant program outcomes.
Kidney Transplant Survival
|1 Year||100%||national average||100%|
|3 Years||98%||national average||98%|
Children's transplant team has performed kidney transplants on hundreds of children and teens, making it one of the most active pediatric kidney transplant centers in the world.
Learn more about Children’s Hospital’s kidney transplant program outcomes.
Blood and Bone Marrow Transplant Survival (2008-March 2012)
|Outcome Measure||Type||Children's Hospital|
|100-Day Survival 1||All**||91%|
|Myeloid Engraftment 2||Cord Blood||100%|
|One-Year Overall Survival 3||All**||77%|
Blood and Marrow Transplantation (BMT) is used to treat a number of cancers, blood diseases and immune disorders that were once considered incurable. The BMT program at Children's is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).
** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.
1 Percentage of patients living one hundred or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)
2 Signs that the new bone marrow or stem cells are engrafting (growing and developing)
3 Percentage of patients living one or more years following the transplant procedure
* Sources: Internal data; Scientific Registry of Transplant Recipients (www.strt.org) January 2014 release
May 5, 2014
May 5, 2014